Moderate Emetic Risk Intravenous Antineoplastic Agent
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.223
Version20220910
PublisherAmerican Society of Clinical Oncology StewardDate2022-09-10T01:02:30-04:00Purpose(Clinical Focus: The purpose of this value set is to represent concepts of moderate emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a moderate emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)
Expansion
| Code | Display | System |
|---|---|---|
| 1726097 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1726319 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 829926 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1594658 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1736784 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1942743 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1791597 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1660004 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1736786 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 835945 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 2267576 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1736781 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 485246 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1791588 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1719772 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1797528 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1660009 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1726324 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 253113 | http://www.nlm.nih.gov/research/umls/rxnorm | |
| 1726492 | http://www.nlm.nih.gov/research/umls/rxnorm |